• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中心性浆液性脉络膜视网膜病变中后部囊样视网膜变性的危险因素。

Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy.

作者信息

Piccolino Felice Cardillo, De La Longrais Roberta Rigault, Manea Marilisa, Cicinelli Simonetta, Ravera Giambattista

机构信息

Fondazione per la Macula Onlus, Genova.

出版信息

Retina. 2008 Oct;28(8):1146-50. doi: 10.1097/IAE.0b013e318175421f.

DOI:10.1097/IAE.0b013e318175421f
PMID:18779722
Abstract

PURPOSE

To identify factors associated with the development of posterior cystoid retinal degeneration (PCRD) in central serous chorioretinopathy (CSC).

METHODS

The authors retrospectively studied 51 eyes of 51 patients with chronic CSC and subretinal or intraretinal exudation documented by optical coherence tomography (OCT), and evaluated the association of hypertension, systemic use of corticosteroids, duration of symptoms, subretinal fibrosis, and large laser scars with the development of PCRD.

RESULTS

Twenty-four eyes (47%) had PCRD and 27 eyes (53%) had serous macular detachment without cystoid retinal changes. Multivariate analysis showed that a duration of symptoms exceeding 5 years (odds ratio [OR], 25.4; 95% confidence interval [CI], 2.8-233.2; P = 0.004) and subretinal fibrosis (OR, 19.1; 95% CI, 1.8-205.1; P = 0.015) were significantly associated with PCRD.

CONCLUSION

Disease duration longer than 5 years and subretinal fibrosis are associated with the development of PCRD in CSC. Prospective evaluations could substantiate the associations found in this study and further clarify their significance.

摘要

目的

确定中心性浆液性脉络膜视网膜病变(CSC)中与后部囊样视网膜变性(PCRD)发生相关的因素。

方法

作者回顾性研究了51例慢性CSC患者的51只眼,这些患者经光学相干断层扫描(OCT)记录有视网膜下或视网膜内渗出,并评估高血压、全身性使用皮质类固醇、症状持续时间、视网膜下纤维化和大面积激光瘢痕与PCRD发生之间的关联。

结果

24只眼(47%)发生了PCRD,27只眼(53%)有浆液性黄斑脱离但无囊样视网膜改变。多因素分析显示,症状持续时间超过5年(比值比[OR],25.4;95%置信区间[CI],2.8 - 233.2;P = 0.004)和视网膜下纤维化(OR,19.1;95%CI,1.8 - 205.1;P = 0.015)与PCRD显著相关。

结论

病程超过5年和视网膜下纤维化与CSC中PCRD的发生相关。前瞻性评估可以证实本研究中发现的关联,并进一步阐明其意义。

相似文献

1
Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变中后部囊样视网膜变性的危险因素。
Retina. 2008 Oct;28(8):1146-50. doi: 10.1097/IAE.0b013e318175421f.
2
Posterior cystoid retinal degeneration in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变中的后部囊样视网膜变性。
Retina. 2008 Jul-Aug;28(7):1008-12. doi: 10.1097/IAE.0b013e31816b4b86.
3
Optical coherence tomography evaluation of detached macula from rhegmatogenous retinal detachment and central serous chorioretinopathy.光学相干断层扫描对孔源性视网膜脱离和中心性浆液性脉络膜视网膜病变所致黄斑脱离的评估
Am J Ophthalmol. 2008 Jun;145(6):1071-1076. doi: 10.1016/j.ajo.2008.01.031. Epub 2008 Mar 28.
4
Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.通过傅里叶域光学相干断层扫描评估急性中心性浆液性脉络膜视网膜病变的形态学变化。
Ophthalmology. 2008 Sep;115(9):1494-500, 1500.e1-2. doi: 10.1016/j.ophtha.2008.01.021. Epub 2008 Apr 18.
5
The optical coherence tomography-ophthalmoscope for examination of central serous chorioretinopathy with precipitates.用于检查伴有沉淀物的中心性浆液性脉络膜视网膜病变的光学相干断层扫描检眼镜。
Retina. 2008 Jun;28(6):864-9. doi: 10.1097/IAE.0b013e3181669795.
6
Differential optical densities of intraretinal spaces.视网膜内间隙的差分光密度
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3529-34. doi: 10.1167/iovs.07-1320. Epub 2008 Apr 25.
7
Morphologic changes in the outer layer of the detached retina in rhegmatogenous retinal detachment and central serous chorioretinopathy.孔源性视网膜脱离和中心性浆液性脉络膜视网膜病变中脱离视网膜外层的形态学变化。
Am J Ophthalmol. 2009 Mar;147(3):489-494.e1. doi: 10.1016/j.ajo.2008.09.030. Epub 2008 Dec 5.
8
Clinical characteristics of subretinal deposits in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变中视网膜下沉积物的临床特征
Acta Ophthalmol Scand. 2005 Dec;83(6):691-6. doi: 10.1111/j.1600-0420.2005.00582.x.
9
Photodynamic therapy in the treatment of chronic central serous chorioretinopathy.光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变
Klin Monbl Augenheilkd. 2006 May;223(5):372-5. doi: 10.1055/s-2006-926567.
10
Optical coherence tomography features of acute central serous chorioretinopathy versus neovascular age-related macular degeneration.急性中心性浆液性脉络膜视网膜病变与新生血管性年龄相关性黄斑变性的光学相干断层扫描特征。
Br J Ophthalmol. 2010 May;94(5):597-9. doi: 10.1136/bjo.2008.149724. Epub 2009 Oct 12.

引用本文的文献

1
Analysis of choroidal markers of activity in pachychoroid disease spectrum.肥厚性脉络膜疾病谱中脉络膜活性标志物的分析
Graefes Arch Clin Exp Ophthalmol. 2025 Apr;263(4):973-984. doi: 10.1007/s00417-025-06740-w. Epub 2025 Jan 24.
2
Peripapillary pachychoroid syndrome: clinical insights.视盘周围厚脉络膜综合征:临床见解
Eye (Lond). 2024 Dec;38(17):3210-3212. doi: 10.1038/s41433-024-03274-z. Epub 2024 Jul 31.
3
Clinical feature of cystoid macular degeneration in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的囊样黄斑变性的临床特征。
Indian J Ophthalmol. 2023 Nov;71(11):3489-3493. doi: 10.4103/IJO.IJO_255_23.
4
Central Serous Chorioretinopathy by Autofluorescence, Enface and SLO-Retromode Imaging.通过自体荧光、正面成像和SLO反模式成像观察中心性浆液性脉络膜视网膜病变
Life (Basel). 2023 Jun 17;13(6):1407. doi: 10.3390/life13061407.
5
Central serous chorioretinopathy: Treatment.中心性浆液性脉络膜视网膜病变:治疗
Taiwan J Ophthalmol. 2022 Nov 28;12(4):394-408. doi: 10.4103/2211-5056.362040. eCollection 2022 Oct-Dec.
6
Longitudinal follow-up and outcome analysis in central serous chorioretinopathy.中浆病的纵向随访和结局分析。
Eye (Lond). 2023 Mar;37(4):732-738. doi: 10.1038/s41433-022-02044-z. Epub 2022 Apr 1.
7
The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy.影像学在中心性浆液性脉络膜视网膜病变治疗规划中的作用
Pharmaceuticals (Basel). 2021 Jan 29;14(2):105. doi: 10.3390/ph14020105.
8
Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review.中心性浆液性脉络膜视网膜病变的当前药物治疗选择:综述
Pharmaceuticals (Basel). 2020 Sep 23;13(10):264. doi: 10.3390/ph13100264.
9
Corticosteroids usage and central serous chorioretinopathy: a meta-analysis.皮质类固醇的使用与中心性浆液性脉络膜视网膜病变:一项荟萃分析。
Graefes Arch Clin Exp Ophthalmol. 2020 Jan;258(1):71-77. doi: 10.1007/s00417-019-04486-w. Epub 2019 Nov 16.
10
Central serous chorioretinopathy: Current update on pathophysiology and multimodal imaging.中心性浆液性脉络膜视网膜病变:病理生理学与多模态成像的最新进展
Oman J Ophthalmol. 2018 May-Aug;11(2):103-112. doi: 10.4103/ojo.OJO_75_2017.